Neisseria meningitidis (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Neisseria meningitidis" in Galician language version.

refsWebsite

Global rank Galician rank

5web.archive.org

1^st place

5nih.gov

4^th place

6^th place

5doi.org

2^nd place

7^th place

3archive.org

6^th place

8^th place

1cdc.gov

218^th place

235^th place

1brown.edu

2,481^st place

1,460^th place

1consultantlive.com

low place

1seimc.org

low place

1meningitisinfo.com

low place

1who.int

195^th place

178^th place

1oup.com

485^th place

312^th place

1worldcat.org

5^th place

11^th place

1hpa.org.uk

low place

1fda.gov

447^th place

749^th place

1sld.cu

5,873^rd place

1,640^th place

1ox.ac.uk

613^th place

779^th place

archive.org

Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 329–333. ISBN 0-8385-8529-9.
Jarrell, K (editor) (2009). Pili and Flagella: Current Research and Future Trends. Caister Academic Press. ISBN 978-1-904455-48-6.
Ullrich, M (editor) (2009). Bacterial Polysaccharides: Current Innovations and Future Trends. Caister Academic Press. ISBN 978-1-904455-45-5.

brown.edu

"Neisseria meningitidis". Brown University. Arquivado dende o orixinal o 10 de novembro de 2009. Consultado o 22 October 2009.

cdc.gov

Neisseria meningitidis at Centers for Disease Control and Prevention. Page last reviewed: 21 xuño 2013

consultantlive.com

Mola SJ, Nield LS, and Weisse ME (February 27, 2008). "Treatment and Prevention of N. meningitidis Infection". Infections in Medicine.

doi.org

dx.doi.org

van Deuren M, Brandtzaeg P, van der Meer JW (2000). "Update on meningococcal disease with emphasis on pathogenesis and clinical management". Clin Microbiol Rev 13 (1): 144–66. PMC 88937. PMID 10627495. doi:10.1128/CMR.13.1.144-166.2000.
Boisier, P.; Nicolas, P.; Djibo, S.; Taha, M.-K.; Jeanne, I.; Mainassara, H. B.; Tenebray, B.; Kairo, K. K.; Giorgini, D. (2007-03-01). "Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger". Clinical Infectious Diseases (en inglés) 44 (5): 657–663. ISSN 1058-4838. doi:10.1086/511646.
Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004). "Practice guidelines for the management of bacterial meningitis". Clin Infect Dis 39 (9): 1267–84. PMID 15494903. doi:10.1086/425368.
Pérez O, Lastre M, Lapinet J, Bracho G, Díaz M, Zayas C, Taboada C, Sierra G (2001). "Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC Vaccine". Infect Immun 69 (7): 4502–8. PMC 98525. PMID 11401992. doi:10.1128/IAI.69.7.4502-4508.2001.
Uli L, Castellanos-Serra L, Betancourt L, Domínguez F, Barberá R, Sotolongo F, Guillén G, Pajón Feyt R (2006). "Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry". Proteomics 6 (11): 3389–99. PMID 16673438. doi:10.1002/pmic.200500502.

fda.gov

FDA approves new combination vaccine that protects children against two bacterial diseases, FDA Press Release, June 14, 2012

hpa.org.uk

Health Protection Agency Meningococcus Forum (August 2006). Guidance for public health management of meningococcal disease in the UK. Available online at: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947389261

meningitisinfo.com

"Copia arquivada". Arquivado dende o orixinal o 06 de xuño de 2013. Consultado o 21 de xuño de 2013.

nih.gov

ncbi.nlm.nih.gov

van Deuren M, Brandtzaeg P, van der Meer JW (2000). "Update on meningococcal disease with emphasis on pathogenesis and clinical management". Clin Microbiol Rev 13 (1): 144–66. PMC 88937. PMID 10627495. doi:10.1128/CMR.13.1.144-166.2000.
Griffiss JM, Schneider H, Mandrell RE, Yamasaki R, Jarvis GA, Kim JJ, Gibson BW, Hamadeh R, Apicella MA. (1988). "Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane". Rev Infect Dis. 10 Suppl 2: S287–95. PMID 2460911.
Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004). "Practice guidelines for the management of bacterial meningitis". Clin Infect Dis 39 (9): 1267–84. PMID 15494903. doi:10.1086/425368.
Pérez O, Lastre M, Lapinet J, Bracho G, Díaz M, Zayas C, Taboada C, Sierra G (2001). "Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC Vaccine". Infect Immun 69 (7): 4502–8. PMC 98525. PMID 11401992. doi:10.1128/IAI.69.7.4502-4508.2001.
Uli L, Castellanos-Serra L, Betancourt L, Domínguez F, Barberá R, Sotolongo F, Guillén G, Pajón Feyt R (2006). "Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry". Proteomics 6 (11): 3389–99. PMID 16673438. doi:10.1002/pmic.200500502.

oup.com

academic.oup.com

Boisier, P.; Nicolas, P.; Djibo, S.; Taha, M.-K.; Jeanne, I.; Mainassara, H. B.; Tenebray, B.; Kairo, K. K.; Giorgini, D. (2007-03-01). "Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger". Clinical Infectious Diseases (en inglés) 44 (5): 657–663. ISSN 1058-4838. doi:10.1086/511646.

ox.ac.uk

ovg.ox.ac.uk

"First ever MenB vaccine available for use" Arquivado 25 de outubro de 2014 en Wayback Machine., Oxford Vaccine Group openminds blog article, 24 January 2013

seimc.org

Julio A. Vázquez. Situación actual de la epidemiología de la enfermedad meningocócica. Laboratorio de Referencia de Neisserias, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda (Madrid). [1] Arquivado 26 de xuño de 2012 en Wayback Machine.

sld.cu

finlay.sld.cu

"Copia arquivada". Arquivado dende o orixinal o 08 de xaneiro de 2011. Consultado o 22 de xuño de 2013.

web.archive.org

"Neisseria meningitidis". Brown University. Arquivado dende o orixinal o 10 de novembro de 2009. Consultado o 22 October 2009.
Julio A. Vázquez. Situación actual de la epidemiología de la enfermedad meningocócica. Laboratorio de Referencia de Neisserias, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda (Madrid). [1] Arquivado 26 de xuño de 2012 en Wayback Machine.
"Copia arquivada". Arquivado dende o orixinal o 06 de xuño de 2013. Consultado o 21 de xuño de 2013.
"Copia arquivada". Arquivado dende o orixinal o 08 de xaneiro de 2011. Consultado o 22 de xuño de 2013.
"First ever MenB vaccine available for use" Arquivado 25 de outubro de 2014 en Wayback Machine., Oxford Vaccine Group openminds blog article, 24 January 2013

who.int

OMS (ed.). "Emergence of W135 Meningococcal Disease" (PDF). Consultado o 17 de maio de 2019.

worldcat.org

Boisier, P.; Nicolas, P.; Djibo, S.; Taha, M.-K.; Jeanne, I.; Mainassara, H. B.; Tenebray, B.; Kairo, K. K.; Giorgini, D. (2007-03-01). "Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger". Clinical Infectious Diseases (en inglés) 44 (5): 657–663. ISSN 1058-4838. doi:10.1086/511646.